Lv41
760 积分 2022-11-04 加入
Balancing weight and muscle loss in GLP1 receptor agonist therapy
1小时前
待确认
Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease
29天前
已完结
The evolution of the obesity drug market
1个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2个月前
已完结
A proteomic signature of healthspan
3个月前
已完结
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials
4个月前
已完结
Sustained anti‐obesity effects of life‐style change and anti‐inflammatory interventions after conditional inactivation of the activin receptor ALK7
5个月前
已完结
Phase I Study of AVE1642 Anti IGF-1R Monoclonal Antibody in Patients with Advanced Multiple Myeloma
5个月前
已完结
Phase I Study of AVE1642 Anti IGF-1R Monoclonal Antibody in Patients with Advanced Multiple Myeloma
5个月前
已完结
Does SLC39A8 Ala391Thr Confer Risk of Chronic Liver Disease?
6个月前
已完结
皖公网安备34019202002308
